Issue navigation
Volume 66, Issue 5, May 2011
Leading Articles
Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 959–963, https://doi.org/10.1093/jac/dkr090
The DART Trial: ‘The Doctor's Dilemma’ revisited
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 964–967, https://doi.org/10.1093/jac/dkr020
Systematic review
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 968–978, https://doi.org/10.1093/jac/dkr040
ORIGINAL RESEARCH
Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 979–984, https://doi.org/10.1093/jac/dkr043
The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 985–996, https://doi.org/10.1093/jac/dkr044
Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 997–1000, https://doi.org/10.1093/jac/dkr059
Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1001–1004, https://doi.org/10.1093/jac/dkr048
Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1005–1012, https://doi.org/10.1093/jac/dkr041
Prevalence and genotypic characteristics of β-lactamase-negative ampicillin-resistant Haemophilus influenzae in Australia
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1013–1015, https://doi.org/10.1093/jac/dkr035
Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1016–1023, https://doi.org/10.1093/jac/dkr021
SmQnrR, a DeoR-type transcriptional regulator, negatively regulates the expression of Smqnr and SmtcrA in Stenotrophomonas maltophilia
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1024–1028, https://doi.org/10.1093/jac/dkr049
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1029–1035, https://doi.org/10.1093/jac/dkr029
Physiological changes induced by the quaternary ammonium compound benzyldimethyldodecylammonium chloride on Pseudomonas fluorescens
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1036–1043, https://doi.org/10.1093/jac/dkr028
Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1044–1046, https://doi.org/10.1093/jac/dkr057
In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1047–1051, https://doi.org/10.1093/jac/dkr069
In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1052–1056, https://doi.org/10.1093/jac/dkr045
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1057–1060, https://doi.org/10.1093/jac/dkr066
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1061–1069, https://doi.org/10.1093/jac/dkr024
Comparative activity of carbapenem testing: the COMPACT study
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1070–1078, https://doi.org/10.1093/jac/dkr056
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1079–1086, https://doi.org/10.1093/jac/dkr054
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1087–1095, https://doi.org/10.1093/jac/dkr033
Evidence of intravenous immunoglobulin as a critical supportive therapy against Clostridium difficile toxin-mediated lethality in mice
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1096–1099, https://doi.org/10.1093/jac/dkr027
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1100–1109, https://doi.org/10.1093/jac/dkr038
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1110–1116, https://doi.org/10.1093/jac/dkr046
‘Septrin psychosis’ among renal transplant patients with Pneumocystis jirovecii pneumonia
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1117–1119, https://doi.org/10.1093/jac/dkr050
Low incidence of renal impairment observed in tenofovir-treated patients
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1120–1126, https://doi.org/10.1093/jac/dkr039
Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1127–1139, https://doi.org/10.1093/jac/dkr034
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1140–1149, https://doi.org/10.1093/jac/dkq511
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1150–1155, https://doi.org/10.1093/jac/dkr089
Cefepime effectiveness in Gram-negative bloodstream infections
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1156–1160, https://doi.org/10.1093/jac/dkr061
Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1161–1167, https://doi.org/10.1093/jac/dkr053
Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1168–1173, https://doi.org/10.1093/jac/dkr047
Research Letters
The new genetic environment of cfr on plasmid pBS-02 in a Bacillus strain
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1174–1175, https://doi.org/10.1093/jac/dkr037
Small qnrB-harbouring ColE-like plasmids widespread in commensal enterobacteria from a remote Amazonas population not exposed to antibiotics
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1176–1178, https://doi.org/10.1093/jac/dkr026
New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1178–1179, https://doi.org/10.1093/jac/dkr030
Report of an outbreak of CO2-dependent methicillin-resistant Staphylococcus aureus on a regional liver transplant unit
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1179–1181, https://doi.org/10.1093/jac/dkr055
Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1181–1182, https://doi.org/10.1093/jac/dkr023
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1182–1184, https://doi.org/10.1093/jac/dkr025
Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1184–1186, https://doi.org/10.1093/jac/dkr060
Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is spread internationally by genetically distinct gonococcal populations
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1186–1187, https://doi.org/10.1093/jac/dkr052
Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1188–1189, https://doi.org/10.1093/jac/dkr032
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: relapse or late IRIS?
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1190–1191, https://doi.org/10.1093/jac/dkr067
Letters to the Editor
Comment on: Performance of the Oxoid M.I.C.Evaluator™ Strips compared with the Etest® assay and BSAC agar dilution
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1192–1193, https://doi.org/10.1093/jac/dkr065
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1193–1194, https://doi.org/10.1093/jac/dkr031
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1194–1195, https://doi.org/10.1093/jac/dkr080
Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1195–1196, https://doi.org/10.1093/jac/dkq490
A potential role for daptomycin in enterococcal infections: what is the evidence?—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1196–1197, https://doi.org/10.1093/jac/dkr051
Comment on: Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1197–1198, https://doi.org/10.1093/jac/dkq474
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1198–1199, https://doi.org/10.1093/jac/dkr036
Comment on: Spondylodiscitis: update on diagnosis and management
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Page 1199, https://doi.org/10.1093/jac/dkq513
Comment on: Spondylodiscitis: update on diagnosis and management
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1199–1200, https://doi.org/10.1093/jac/dkq532
Spondylodiscitis: update on diagnosis and management—authors’ responses
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1200–1202, https://doi.org/10.1093/jac/dkr079
Errata
One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Page 1203, https://doi.org/10.1093/jac/dkr063
Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Page 1204, https://doi.org/10.1093/jac/dkr064
